🙏Thanks to Prof Arlt for refering on our protocol trial:➡️ PPI and LAMS complication at #UEGWeek 🇩🇰

👉If you are a 🇪🇺endoscopist please fill in our expert survey! redcap.umg.eu/surveys/?s=AJ8…

👉You apply a lot of LAMS in your center? Join our clinical trial ➡️📨

🚨 #UEGWeek Phase 3b SEQUENCE: RZB vs UST for pts with #CD

✅Primary endpoints BOTH met:
📌RZB non-inferior to UST for clinical remission at wk 24
📌RZB superior to UST for endoscopic remission at wk 48❗️

💎 Superiority for all secondary endpoints, similar safety profiles

1️⃣ day to go #myUEGcommunity ! The ⏰ is literally ticking until tomorrow’s Friday, April 26 abstract submission deadline for #UEGWeek 2024. Head to our website and send in your science right now ➡️ bit.ly/4bT1OEm

Fabulous talk on diet in IBD by Kevin Whelan at #UEGWeek
my_UEG

An honnor to chair the first IBD session of #UEGWeek with Prof Matthieu Allez
#Mat (t)hieu x 2

🎓 Join our Postgraduate Teaching (PGT) Programme during #UEGWeek 2024! 💡 Dive into 2 days of engaging learning experience. We bring you interactive live voting, tricky clinical cases, controversial debates & real-time engagement with faculty. Learn more: bit.ly/3NBtjp7

🙌🏼 Huge thanks to the scientific committee at my_UEG for selecting my abstract and to everyone who joined my talk.
Also, a big shoutout to the organisers for an incredible event with a fantastic scientific and clinical program – looking forward to next year's #UEGWeek already!

Beautiful Copenhagen
#UEGweek

Outstanding CCR surveillance in IBD #iacucci
Great lecture ! #uegweek

Gratitude to my_UEG for affording me the privilege to present our research findings regarding the influence of high-barrier NUCs on HBV patients awaiting liver transplantation 🦠

📢🔜 I look forward to meeting you tomorrow at 1 pm, Poster Stage 2

#livertwitter
#UEGWeek

🚨 #UEGWeek New MoA alert❗️

💎 Obefazimod in pts with #UC : 96wk OL maintenance 2B Severine Vermeire

🧬 MoA: miR-124 upregulation (originally developed for HIV)
📌 50mg oral once-daily
📌 Clinical remission maintained up to 2 years (52.5%)
📌 Safe with good tolerability

52 week results from treatment with resmiterom

1. More NASH resolution
2. More fibrosis regression, including 1/10 experiencing a 2-stage reduction
3. Lower LDL

❤️this #uegweek
👏Jörn Schattenberg

Delighted to announce that I'll be taking the stage at #UEGWeek in Copenhagen 🇩🇰 this year to share the results of my PhD with an oral presentation! Get ready to dive into the world of early detection of #cholangiocarcinoma with me! 📊🎙️my_UEG

🗓️ 17 Oct 10:00
#CCAResearch

All good things must come to an end, including our abstract submission period. (➡️ bit.ly/4bT1OEm) #UEGWeek and our multidisciplinary, internationally renowned stages await.

Believe in yourself. Believe in your science. Submit your abstract by today’s deadline.

Excited to have 2 abstracts (retrospective study and clinical case) accepted for poster presentation at #UEGWeek my_UEG

With 3 colleagues from Ukraine in #UEGweek

Kudos for those who dare with face to face trials in #IBD . This is the way. #UEGWeek

Still recovering from #UEGWeek ... What an amazing Congress! Thanks my_UEG Community for everything, including Let's Meet & UEG Night 😉 and my Rising 🌟Award! Looking forward to #UEGWeek 2024 in Vienna!

Honored to present on behalf of incredible colleagues in #RubinLab UChicagoIBD under mentorship of David T. Rubin, MD at #UEGWeek on risk factors for acne on upadacitinib. Grateful for the wonderful moderators Matthieu Allez Mathieu Uzzan in the first moderated poster session of #UEGW2023 .

📢Join me today #UEGWeek for my_UEG Rising 🌟 Award Talk on Pancreatic Cancer Early Detection! #pancreas 👇